Position in NTLA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$15,739,525
-$31,695,534 QoQ
Shares Held
930,232
-66.1% QoQ
Ownership
0.664%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#31
of 330 holders
Holding Since
Mar 2020
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NTLA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026BAKER BROS. ADVISORS LP holds $18,875,530,286 across 78 Biotechnology names. NTLA ranks #57 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INCY |
Incyte Corp
|
30,762,330 | $3,487,217,728 | |
| 2 | ONC |
BeOne Medicines Ltd.
|
8,801,567 | $2,508,182,547 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
11,443,357 | $2,143,111,898 | |
| 4 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
2,143,131 | $1,150,754,190 | |
| 5 | ACAD |
Acadia Pharmaceuticals Inc
|
42,912,904 | $1,085,696,471 | |
| 6 | KYMR |
Kymera Therapeutics, Inc.
|
8,657,242 | $992,725,940 | |
| 7 | INSM |
INSMED Inc
|
8,796,111 | $937,841,354 | |
| 8 | CELC |
Celcuity Inc.
|
7,915,792 | $828,150,159 |
All Filings in NTLA
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $15,739,525 | 930,232 | Shares | Sole | 2026-08-14 | |
| 2025-09-30 | $47,435,059 | 2,746,674 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $25,097,822 | 2,675,674 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $4,579,664 | 644,116 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $7,510,392 | 644,116 | Shares | Sole | 2025-02-14 | |
| 2020-12-31 | $6,054,502 | 111,296 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $2,430,091 | 122,238 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $2,701,868 | 128,538 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $1,572,019 | 128,538 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||